ChaseDog31 Tuesday, 09/29/20 10:36:45 AM Re: None Post # of 17487 Recently it was said here that NDTP could just be an attempt to monetize the Fountain tech from 2013 to present. This would be done thru licensing to larger pharma concerns. Also there has been talk of a possible brain injury protection drink that could be launched using this same technology. And now we see that Dr. Kester is a principal in this new company. When i read his bio i am struck by how cutting edge his stuff is. I do not think you bring in a guy like this just to further the Fountain tech. His "stuff" is fresh. Something is up. There appears to be a plan. My conclusion is why not exploit all three possibilities. License the Fountain tech, do a drink line, and let our new "mad scientist" loose. I have a feeling that Hovis is just a place setter, and that an operational CEO with pharmaceutical experience will be hired soon. Then Hovis can go work on bringing a drink to market, something he has done successfully in the past. Stay tuned. This could get really interesting really fast.